Jeff Jones

Stock Analyst at Oppenheimer

(1.81)
# 3,340
Out of 5,043 analysts
94
Total ratings
28.24%
Success rate
-5.07%
Average return

Stocks Rated by Jeff Jones

Ventyx Biosciences
Oct 27, 2025
Maintains: Outperform
Price Target: $9$14
Current: $7.30
Upside: +91.78%
Kymera Therapeutics
Oct 1, 2025
Maintains: Outperform
Price Target: $53$63
Current: $61.48
Upside: +2.47%
Pelthos Therapeutics
Sep 2, 2025
Initiates: Outperform
Price Target: $50
Current: $31.36
Upside: +59.44%
Chemomab Therapeutics
Aug 27, 2025
Maintains: Outperform
Price Target: $10$25
Current: $3.13
Upside: +700.00%
Corbus Pharmaceuticals Holdings
Aug 6, 2025
Maintains: Outperform
Price Target: $56$53
Current: $17.44
Upside: +203.90%
ArriVent BioPharma
Jun 24, 2025
Maintains: Outperform
Price Target: $39$44
Current: $19.85
Upside: +121.66%
Alumis
May 15, 2025
Maintains: Outperform
Price Target: $26$25
Current: $4.83
Upside: +417.60%
Zura Bio
May 9, 2025
Maintains: Outperform
Price Target: $19$17
Current: $3.86
Upside: +340.41%
Corvus Pharmaceuticals
May 9, 2025
Reiterates: Outperform
Price Target: $15$17
Current: $7.70
Upside: +120.78%
Immunocore Holdings
May 8, 2025
Maintains: Outperform
Price Target: $85$86
Current: $33.99
Upside: +153.02%
Maintains: Outperform
Price Target: $28$18
Current: $7.44
Upside: +141.94%
Downgrades: Perform
Price Target: n/a
Current: $3.52
Upside: -
Maintains: Outperform
Price Target: $22$16
Current: $2.94
Upside: +444.22%
Maintains: Outperform
Price Target: $48$45
Current: $1.79
Upside: +2,421.01%
Downgrades: Perform
Price Target: n/a
Current: $17.11
Upside: -
Reiterates: Perform
Price Target: n/a
Current: $1.28
Upside: -
Downgrades: Perform
Price Target: n/a
Current: $6.03
Upside: -
Reiterates: Outperform
Price Target: $15
Current: $1.51
Upside: +893.38%
Reiterates: Outperform
Price Target: $75
Current: $0.48
Upside: +15,515.24%
Maintains: Outperform
Price Target: $1,600$1,100
Current: $6.63
Upside: +16,491.25%